Melanocortin Peptides
Melanotan I and II, PT-141 (bremelanotide) and other melanocortin-receptor agonists.
-
PT-141 (bremelanotide): benefits, evidence and legal status
PT-141, now called bremelanotide, is a synthetic cyclic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone (α-MSH) that the FDA approved on June 21, 2019 as Vyleesi, for one narrow use: acquired,…